In turn, the company—which is broadly seeking to develop inflammatory drugs targeting the complement system—anticipates ...

Steven Daniel Daveluy, MD, FAAD, discussed how artificial intelligence (AI) can leverage extensive patient data and guide dermatologists to improve early diagnosis and treatment of rare dermatological ...

A rare and potentially fatal skin infection with nightmarish outcomes may soon have a cure. The infection starts as a seemingly harmless rash, and before a person knows it, more than 30 percent of the ...

SALT LAKE CITY (ABC4) — A Utah woman is sharing her story after she survived an incredibly rare and often fatal skin disorder caused by an allergic reaction to antibiotics. Brandi Nicole Pond, who ...

The symptoms: A man went to the dermatology department of a hospital after experiencing an array of symptoms for about three ...

Please provide your email address to receive an email when new articles are posted on . The researchers were tasked with helping a patient who had a novel form of recalcitrant erythroderma. Using a ...

Argyria is caused by a buildup of silver in the body, which discolors the skin. When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works. A rare condition ...

The webinar will explore PC111, a novel monoclonal antibody drug candidate with the potential to transform the treatment landscape for Pemphigus Vulgaris and Stevens-Johnson Syndrome/Toxic Epidermal ...

Palvella Therapeutics, Inc. announced the issuance of a new patent for its lead product, QTORIN™ 3.9% rapamycin anhydrous gel, which provides substantial protection for its topical composition and ...

SALT LAKE CITY (KTVX) — A Utah woman is sharing her story after she survived an incredibly rare and often fatal skin disorder caused by an allergic reaction to antibiotics. “I’m lucky to be alive, I’m ...